Fetomaternal outcome in patients with early preterm labour following administration of magnesium sulphate - a hospital based prospective study
Objective: To assess the effectiveness of magnesium sulfate as a neuroprotective agent in early preterm labour (28 to 32 weeks). To assess any maternal or fetal adverse effects after giving magnesium sulfate. Methods: Hospital based prospective observational study. Initially 72 pregnant women with p...
Saved in:
Main Authors: | Robin Medhi (Author), Indira Das (Author), Rumen Ch Boro (Author), Wahida Naznin (Author) |
---|---|
Format: | Book |
Published: |
Barpeta Obstetrics and Gynaecological Society,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
by: Akira Kobayashi, et al.
Published: (2023) -
Does Antenatal Administration of Magnesium Sulphate Prevent Cerebral Palsy and Mortality in Preterm Infants? A Study Protocol.
by: Hanne Trap Wolf, et al.
Published: (2015) -
Prenatal therapy with magnesium sulphate and intestinal obstruction due to meconium in preterm newborns
by: Ainhoa Gochi Valdovinos, et al.
Published: (2022) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017) -
Magnesium sulphate for fetal neuroprotection Sulfato de magnésio para neuroproteção fetal
by: Fabricio da Silva Costa, et al.
Published: (2011)